These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8878462)

  • 41. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.
    Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H
    Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
    Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J
    Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
    Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody.
    Chen Q; Yuan S
    J Cancer Res Clin Oncol; 1994; 120(11):668-71. PubMed ID: 7962043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.
    Liu Z; Zhou X; Shi Y; Du S; Yang Y; Tang J; Shen Y
    Cancer Biother Radiopharm; 2011 Apr; 26(2):229-35. PubMed ID: 21510749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
    Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
    Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and biodistribution of a mouse/human chimeric antibody directed against pancreatic cancer mucin.
    Hirayama K; Chung YS; Sawada T; Kim YS; Sowa M
    Cancer; 1995 Mar; 75(6 Suppl):1545-53. PubMed ID: 7889489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung.
    Stein R; Goldenberg DM; Thorpe SR; Mattes MJ
    J Nucl Med; 1997 Mar; 38(3):391-5. PubMed ID: 9074526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody.
    Yao Z; Sakahara H; Zhang M; Kobayashi H; Nakada H; Yamashina I; Konishi J
    Nucl Med Biol; 1995 Feb; 22(2):199-203. PubMed ID: 7767313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
    Gold DV; Goldenberg DM; Karacay H; Rossi EA; Chang CH; Cardillo TM; McBride WJ; Sharkey RM
    Cancer Res; 2008 Jun; 68(12):4819-26. PubMed ID: 18559529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Nucl Med Biol; 1998 Jan; 25(1):37-45. PubMed ID: 9466360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125].
    Klapdor R; Montz R; Greten H; Chatal JF; Douillard JY; Saccavini JC; Dietel M
    Nuklearmedizin; 1985 Dec; 24(5-6):227-31. PubMed ID: 3867855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
    Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative autoradiographic evaluation of the influence of protein dose on monoclonal antibody distribution in human ovarian adenocarcinoma xenografts.
    Yang FE; Brown RS; Koral KF; Clavo AC; Jackson GA; Wahl RL
    Cancer Immunol Immunother; 1992; 35(6):365-72. PubMed ID: 1394341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.